Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ear Wax MD
- Development stage
- Unknown
- Lead developer
- EOSERA
- Modality
- Small Molecules
- Administration
- Otic
01
Overview
Ear Wax MD is an over-the-counter (OTC) cerumenolytic otic solution developed by Eosera for the clearance of excess earwax (cerumen) buildup. The formulation contains a proprietary blend of ingredients including water, glycerin, sodium bicarbonate, glycolic acid, potassium bicarbonate, benzyl alcohol, and benzalkonium chloride. It works by breaking down and dissolving the lipids and proteins that make up earwax, facilitating its easy removal. It is marketed as topical ear drops, sometimes packaged with a rinse bulb, and is also available in a formulation for children (Ear Wax MD for Kids).
- Brand names
- Ear Wax MDEar Wax MD for KidsEar Wax MD for Kids KitEar Wax MD Kit
- Other names
- Eosera Ear Wax MD
Beyond the preview
Go deeper on Ear Wax MD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ear Wax MD.